During the past decade, Wheaton Franciscan Healthcare - St. Joseph conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wheaton Franciscan Healthcare - St. Joseph" #1 sponsor was "AMAG Pharmaceuticals, Inc." with 1 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wheaton Franciscan Healthcare - St. Joseph" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Alberta Innovation and Science" with 1 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Wheaton Franciscan Healthcare - St. Joseph" are "Acute Coronary Syndrome" (1 trials), "Ambulatory Care" (1 trials), "Breast Cancer" (1 trials), "Bronchopulmonary Dysplasia" (1 trials) and "Cancer-related Problem/Condition" (1 trials). Many other conditions were trialed in "Wheaton Franciscan Healthcare - St. Joseph" in a lesser frequency.

Most popular intervention types in "Wheaton Franciscan Healthcare - St. Joseph" are "Drug" (5 trials), "Device" (4 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "5-fluorouracil" (1 trials), "Apixaban" (1 trials), "BAROSTIM NEO® System" (1 trials) and "Glad Press 'n Seal" (1 trials). Other intervention names were less common.

The vast majority of trials in "Wheaton Franciscan Healthcare - St. Joseph" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Wheaton Franciscan Healthcare - St. Joseph". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Wheaton Franciscan Healthcare - St. Joseph, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wheaton Franciscan Healthcare - St. Joseph, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".